BEAMER

💛 🎉 The BEAMER Project is excited to be Exhibitors at the 6th Digital Health Society Summit from 5-6 November 2024! The #DHSSummit24 is a virtual event organised by The Digital Health Society and ECHAlliance - The Global Health Connector   This year’s theme, “Modernisation in healthcare in the next five years: How will healthcare embrace digitalisation and catch up with other sectors?” will showcase innovation, research, and address the latest digital and data challenges facing #DigitalHealth.   ✅ Over 1,200 registrations from across the globe expected ✅ Free registration ✅ International high-level speakers ✅ Networking opportunities   Do not miss the opportunity to be part of this global conversation. Register here: https://lnkd.in/gkHzuG_e #DHSSummit24 Karolina Mackiewicz BRIAN O'CONNOR

There are 2 things in this publication that really caught my eye. Firstly, this publication builds the case for payers to include adherence in reimbursement agreements, and for governments and policy makers to collaborate with the pharmaceutical industry on how to gain most benefit from prescribed medicine. Secondly, this research is funded in 2011(!) by our BEAMER partner Merck Group which shows their ongoing commitment to improve adherence to treatment. And today this is reflected by the passion and efforts Teodora Caragea and Fulvio Michelis, PhD put into BEAMER. #beamerproject #patientadherence #patientengagement #clinicalcare #clinicaloperations #healthcareinnovations #patientoutcomes #healtheconomics #healthcareprofessionals #healthinsurancepolicy #regulators

An older but still very relevant publication by Alain Golay about the health-economic impact of non-adherence to treatment. The obvious benefit of good adherence to treatment is an improvement of the condition, but there is so much more to gain. Think about the reduced risk of psycho-social complications, the more cost-effective use of healthcare resources, and the improved health-related quality of life. At Link2Trials we believe that improving adherence to treatment can already start in clinical research. This is why we have developed our ARM services, and why we are involved in the BEAMER project. Keep following Link2Trials and BEAMER to stay up to date as we will post more details about the amazing adherence model the team is developing! https://lnkd.in/e8pryAc8 #beamerproject #patientadherence #patientengagement #clinicalresearch #clinicalcare #clinicaloperations #healthcareinnovations #patientoutcomes #healtheconomics #healthcareprofessionals #healthinsurancepolicy #regulators

💛 Recently the #BEAMER project team gathered in Düsseldorf for an intensive two-day workshop! The focus was on the official reveal of the #BEAMER model and preparation for pilot site implementation, making sure the model is ready to meet real-world needs. 💡 Stay tuned for more updates as we continue our mission to improve treatment adherence and health outcomes! https://beamerproject.eu/ #BEAMERProject #HealthcareInnovation #TreatmentAdherence 

🔍 Curious About How BEAMER Can Enhance Patient Adherence in Your Practice? As a healthcare professional, you understand the critical importance of patient #adherence to treatment plans. But have you ever wondered how innovative models like BEAMER could transform your approach? 💛In our September BEAMER Project Newsletter, we began spotlighting personas like Galina to showcase how we tailor our model will meet real-world needs. Who is Galina? Galina is a managerial healthcare professional who would be deeply involved in implementing the BEAMER model within healthcare facilities. Why Personas Matter: Personas like Galina help us understand the challenges and needs of various stakeholders. By crafting detailed, research-based profiles, we can help to ensure that BEAMER is practical and impactful. By understanding and addressing Galina’s needs, we aim to make BEAMER a valuable resource for improving patient outcomes. Read more about Galina here: https://lnkd.in/eEyVMwZf PredictBy Universidad Politécnica de Madrid empirica Communication and Technology Research Jessica Paul Stephan Schug Giuseppe Fico Francisco Lupiañez-Villanueva Claire Everitt Link2Trials Ana Roca-Umbert Würth

🚀 Welcome to the September Edition of the #BEAMER Project Newsletter! This month, we’re focusing on a critical aspect of our project: understanding the people who will benefit most from the BEAMER Model. Personas—research-based representations of different stakeholder types—are helping us design effective, tailored support for patients and the wider healthcare community. The BEAMER Model is a disease-agnostic framework that predicts adherence behavior and segments the population based on actionable factors. Our goal? To build digital health solutions that promote better outcomes for everyone! If you haven't subscribed, follow the link and read our newsletter here: ➡ https://lnkd.in/gQjAKvNq #AdherenceToTreatment empirica Communication and Technology Research Fulvio Michelis, PhD Jessica Paul Stephan Schug Giuseppe Fico Francisco Lupiañez-Villanueva Claire Everitt Link2Trials Ana Roca-Umbert Würth Bea Merino, PhD PredictBy Universidad Politécnica de Madrid Karolina Mackiewicz ECHAlliance - The Global Health Connector

Last Friday, I had the pleasure of speaking at the World Adherence Forum in Brussels, where I discussed the barriers and facilitators to implementing solutions for managing medication adherence from the HTA/payer perspective. Despite the significant societal burden of non-adherence and some evidence supporting cost-effectiveness, only a few adherence-enhancing interventions are currently reimbursed. This was a major event organized by the COST Action ENABLE, chaired by Job van Boven.

Really looking forward to meet everyone in person again. And very anxious to learn more about the simplicity of the BEAMER model and how it will help HCP's to pinpoint what support each patient needs to improve adherence to treatment. #beamerproject #patientadherence #patientengagement #clinicalcare #clinicaloperations #healthcareinnovations #patientoutcomes #healtheconomics #healthcareprofessionals #healthinsurancepolicy #regulators

📣Had an amazing time at #NI2024 in Manchester, UK. In addition to catching up with former colleagues, I met many new interesting people and learned about their research and interests in #nursinginformatics. 🌟 One of the highlights of the last few days was presenting a poster of the BEAMER project. I am happy to share that there was a lot of engagement and enthusiasm for the project 🥳 🤝A big thank you to the poster's co-authors Anne Moen and Jim Ingebretsen Carlson, PhD and of course to rest of the BEAMER team. University of Oslo | Det medisinske fakultet UiO | Innovative Health Initiative (IHI) | #BEAMERProject

𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁… ... for 2019, the Integrated Benefits Institute estimated the annual cost for the U.S. of poor health in the workplace at $575 billion? And that for Europe the costs of absence from work for that same year are estimated at $392 billion? Improving adherence to treatment can help bring these numbers down.   Did you know that non-adherence also happens in clinical trials? Read this article and learn to recognize which clinical trials are at risk of low adherence. 𝗞𝗲𝗲𝗽 𝘆𝗼𝘂𝗿 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗶𝗻𝗳𝗼𝗿𝗺𝗲𝗱—𝗹𝗶𝗸𝗲 𝗮𝗻𝗱 𝘀𝗵𝗮𝗿𝗲 𝘁𝗵𝗶𝘀 𝗽𝗼𝘀𝘁 and 𝗳𝗼𝗹𝗹𝗼𝘄 𝘂𝘀! #Adherence #NonAdherence #ClinicalTrials #BEAMER